A long acting biodegradable controlled delivery of chitosan microspheres loaded with tetanus toxoide as model antigen

Biomedicine and Pharmacotherapy

Volumn 68, Issue 2, 2014, Pages 225-230

  Varma, Sujith ^a   Sadasivan, C ^b  

^a National college of pharmacy   (India)

^b KANNUR UNIVERSITY   (India)

Author keywords

Chitosan microspheres; Tetanus toxoide; Vaccines

Indexed keywords

CHITOSAN; MICROSPHERE; TB 0207; TETANUS TOXOID; UNCLASSIFIED DRUG;

ADSORPTION; ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; IN VITRO STUDY; PARTICLE SIZE; PASSIVE ADSORPTION; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL;

CHITOSAN MICROSPHERES; TETANUS TOXOIDE; VACCINES;

ANTIGENS; BIOCOMPATIBLE MATERIALS; CHEMISTRY, PHARMACEUTICAL; CHITOSAN; CROSS-LINKING REAGENTS; DELAYED-ACTION PREPARATIONS; DRUG CARRIERS; DRUG COMPOUNDING; DRUG STABILITY; ENZYME-LINKED IMMUNOSORBENT ASSAY; MICROSPHERES; PARTICLE SIZE; SOLUBILITY; SURFACE PROPERTIES; TETANUS TOXOID;

EID: 84897030522     PISSN: 07533322     EISSN: 19506007     Source Type: Journal    
DOI: 10.1016/j.biopha.2013.08.009     Document Type: Article

References (31)

1. Bloom B.R. Vaccines for the third world. Nature 1989, 342:115.
2. World Health Organization Programme for Vaccine Development and Transdisease Vaccinology 1989, MIM/EX-BUD.89.1.
3. WHO/UNDP Programme for Vaccine Development. Moving Towards New Vaccines. Information leaflets 1990.
4. Wise D.L., Fellman T.D., Sanderson J.E., Wentworth R.L. Lactide/glycolide polymers used as surgical suture material, raw material or oste osynthesis and in sustained release of drugs. Drug Carrier in Medicine 1979, 237-270. Academic Press, London. G. Gregoriadis (Ed.).
5. BIoddegradales and Delivery Systems for Contraception Progress in Contraceptive Delivery Systems 1980, Vol.1. MTP press, Lancaster.
6. Pitt C.G., Marks T.A., Schindler A. Biodegradable delivery systems based on aliphatic polyesters: application to contraceptives and narcotic antagonist. Controlled Release of Bioactive materials 1984, 19-43. Academic, New York. R. Baker (Ed.).
7. Nash H.A. Controlled release systems for contraception. Medical Applications of Controlled Release 1984, 36-64. CRC Press, Boca Raton. R.S. Langer, D.L. Wise (Eds.).
8. Lewis D.H. Controlled release of bioactive agents from lactide/glycolide polymers. Biodegradable polymers as Drug Delivery Systems 1990, 1-42. Marcel Dekker, New York. M. Chasin, R. Langer (Eds.).
9. Pitt C.G. Poly (e{open}-caprolactone) and its copolymers. Biodegradable Polymers as Drug Delivery Systems 1990, 71-120. Marcel Dekker, New York. M. Chasin, R. Langer (Eds.).
10. Gangrade N., Price J.C. Poly (hydroxyl butyrate-hydroxy valerate) microspheres containing progesterone: preperation, morphology and release properties. J Microencapsul 1991, 8:185-202.
11. Deluca P.P., Mehta R.C., Hausberger A.G., Thanoo B.C. Biodegradable polyesters for drug and polypeptides delivery. Polymeric delivery Systems: properties and applications 1993, 53-79. ACS symp. Ser, Am, Chem. Soc, Washington, DC. M.A.E.I. Nokaly, D.M. Piatt, B.A. Carpentier (Eds.).
12. Morimoto Y., Fugimoto S. Therapeutic drug carrier system. CRC Crit Rev 1983, 2:19.
13. Micropsheres and drug therapy: pharmaceutical, immunological and medical aspects 1984, 309. Elsevier, Amsterdam. E.P. Gold Berg, H. Iwata, W.E. Longo, S.S. Davis, L. Illum, J.G. Mcvie, Tomlinson E. (Eds.).
14. Thanoo B.C., Sunny M.C., Jayakrishnan A. Cross-linked microspheres: preparation and evaluation as a matrix for the controlled release of pharmaceuticals. J Pharm Pharmacol 1992, 44:283.
15. Putney S.D., Burke P.A. Improving protein therapeutics with sustained release formulations. Nat Biotechnol 1998, 16:153-157.
16. Van de Weert M., Hennink W.E., Jiskoot W. Protein instability in poly (lactic-co-glycolic acid) microparticles. Pharm Res 2000, 17:1159-1167.
17. Zhu G., Mallery S.R., Schwendeman S.P. Stabilization of proteins encapsulated in injectable poly(lactide-co-glycolide). Nat Biotechnol 2000, 18:52-57.
18. Tamber H., Johansen P., Merkle P., Gander B. Formulation aspects of biodegradable polymeric microspheres for antigen delivery. Adv Drug Delivery Rev 2005, 57:357-376.
19. Alonso J., Cohen S., Park T.G., Gupta R.K., Siber G.R., Langer R. Determinants of release rate of tetanus vaccine from polyester microspheres. Pharmaceut Res 1993, 51:945-953.
20. Schwendeman S.P., Costantino H.R., Gupta R.K., Tobio M., Chang A.C., Alonso M.J., et al. Strategies for stabilizing tetanus toxoide towards the development of a single-dose tetanus vaccine delivery. Dev Biological Standard 1996, 87:293-306.
21. Zhu G., Mallery S.R., Schwendeman S.P. Stabilization of protein encapsulated in injectable poly (lactide-co-glycolide). Nat Biotechnol 2000, 18:52-57.
22. Chitin, Chitosan and related Enzymes 1984, XVII. Academic press, Orlando, FL, USA. J.P. Zikakis (Ed.).
23. Chitin in nature and technology 1986, Plenum, New York. R. Muzzarelli, C. Jeuniaux, G.W. Gooday (Eds.).
24. Varma S., Sadasivan C. Development of cross-linked chitosan microspheres for prolonged delivery of macromolecular drugs. IJRPC 2011, 1(2):189-192.
25. Jammela S.R., Amit M., Jayakrishnan A. Cross-linked chitosan microspheres as carrier for prolonged delivery of macromolecular drugs. J. Biomater Sci Poly Ed 1994, 621-632.
26. Longo W.E., Iwata H., Lindheeimer T.A., Goldberg E.P. Preperation of hydrophilic albumin microspheres using polymeric dispersing Agents. J. Pharm Sci 1982, 12:1322-1328.
27. Ohya Y., Shiratani M., Kobayashi H., Ouchi T. Release behaviour of %-fluorouracil from chitosan-gel nanospheres immobilizing 5 flurouracil coated with polysaccharides and their cell specific cytotoxicity. Pre Appl Chem 1994, 31:629-642.
28. Jaganathan K.S., Rao Y.U.B., Paramjith D., Swati G., Anubhav J., Vyas S.P. Development of a single dose tetanus toxoide formulation based on polymeric microspheres/a comparative study of Poly (D,L-lactic-co-glycolic acid) versus chitosan microspheres. Int J Pharmaceut 2005, 294:23-32.
29. Thanoo B.C., Jayakrishnan A. Preparation of hydrogel beads from crosslinked poly (methyl methacrylate) microspheres by alkaline hydrolysis. J Appl Polym Sci 1990, 39:1153-1161.
30. Yogesh K.K., Muthukumaran T., Panda A.K. Influence of particle size, antigen load, dose and additional adjuvant on the immune response from antigen loaded PLA microparticles. Int J Pharmaceut 2005, 301:149-160.
31. Inmaculada E., Thomas K. Parameters affecting the immunogenicity of microencapsulated tetanus toxoid. Vaccines 1992, 10:714-720.